Detection of SARS-CoV-2 Based on Nucleic Acid Amplification Tests (NAATs) and Its Integration into Nanomedicine and Microfluidic Devices as Point-of-Care Testing (POCT)
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms241210233 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Alexis Dorta-Gorrín und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology, Faculty of Medicine, University of Cantabria (UC), 39011 Santander, Spain. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de investigación Valdecilla, Ministry of Innovation and Science of Spain.
Abstract (Originalsprache)
The coronavirus SARS-CoV-2 has highlighted the criticality of an accurate and rapid diagnosis in order to contain the spread of the virus. Knowledge of the viral structure and its genome is essential for diagnosis development. The virus is still quickly evolving and the global scenario could easily change. Thus, a greater range of diagnostic options is essential to face this threat to public health. In response to the global demand, there has been a rapid advancement in the understanding of current diagnostic methods. In fact, innovative approaches have emerged, leveraging the benefits of nanomedicine and microfluidic technologies. Although this development has been incredibly fast, several key areas require further investigation and optimization, such as sample collection and preparation, assay optimization and sensitivity, cost effectiveness, scalability device miniaturization, and portability and integration with smartphones. Addressing these gaps in the knowledge and these technological challenges will contribute to the development of reliable, sensitive, and user-friendly NAAT-based POCTs for the diagnosis of SARS-CoV-2 and other infectious diseases, facilitating rapid and effective patient management. This review aims to provide an overview of current SARS-CoV-2 detection methods based on nucleic acid detection tests (NAATs). Additionally, it explores promising approaches that combine nanomedicine and microfluidic devices with high sensitivity and relatively fast ‘time to answer’ for integration into point-of-care testing (POCT).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Molecular Biology, Faculty of Medicine, University of Cantabria (UC), 39011 Santander, Spain.
- Instituto de Investigación Valdecilla (IDIVAL), 39011 Santander, Spain.
- Environmental Genetics Department, Ecohydros S.L., 39600 Maliaño, Spain.
- Microbiology Service of University Hospital Marqués de Valdecilla (HUMV), 39008 Santander, Spain.
- CIBER de Enfermedades Infecciosas-CIBERINFEC (CB21/13/00068), Instituto de Salud Carlos III, 28029 Madrid, Spain.
- Department of Functional Biology, Area of Genetics, Faculty of Medicine, University of Oviedo, 33006 Oviedo, Spain.
ORCID-Profile: Alexis Dorta-Gorrín, Jesús Navas-Méndez, Laura Miralles, Lorena García-Hevia
Förderung
- Instituto de investigación Valdecilla
- Ministry of Innovation and Science of Spain
Zitieren
APA
Dorta-Gorrín, A., Navas-Méndez, J., Gozalo-Margüello, M., Miralles, L., & García-Hevia, L. (2023). Detection of SARS-CoV-2 Based on Nucleic Acid Amplification Tests (NAATs) and Its Integration into Nanomedicine and Microfluidic Devices as Point-of-Care Testing (POCT). International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241210233
Vancouver
Dorta-Gorrín A, Navas-Méndez J, Gozalo-Margüello M, Miralles L, García-Hevia L. Detection of SARS-CoV-2 Based on Nucleic Acid Amplification Tests (NAATs) and Its Integration into Nanomedicine and Microfluidic Devices as Point-of-Care Testing (POCT). International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241210233
BibTeX
@article{DortaGorrn2023,
author = {Dorta-Gorrín, Alexis and Navas-Méndez, Jesús and Gozalo-Margüello, Mónica and Miralles, Laura and García-Hevia, Lorena},
title = {Detection of SARS-CoV-2 Based on Nucleic Acid Amplification Tests (NAATs) and Its Integration into Nanomedicine and Microfluidic Devices as Point-of-Care Testing (POCT)},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms241210233}
}
EUVIMED